CIBC Asset Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $983K | Sell |
6,479
-648
| -9% | -$98.3K | ﹤0.01% | 669 |
|
2025
Q1 | $1.07M | Sell |
7,127
-175
| -2% | -$26.3K | ﹤0.01% | 670 |
|
2024
Q4 | $1.35M | Sell |
7,302
-229
| -3% | -$42.3K | ﹤0.01% | 639 |
|
2024
Q3 | $1.48M | Buy |
7,531
+595
| +9% | +$117K | ﹤0.01% | 626 |
|
2024
Q2 | $1.43M | Sell |
6,936
-299
| -4% | -$61.8K | 0.01% | 617 |
|
2024
Q1 | $1.96M | Buy |
7,235
+217
| +3% | +$58.8K | 0.01% | 576 |
|
2023
Q4 | $1.66M | Sell |
7,018
-207
| -3% | -$48.9K | 0.01% | 588 |
|
2023
Q3 | $1.42M | Sell |
7,225
-66
| -0.9% | -$12.9K | 0.01% | 596 |
|
2023
Q2 | $1.53M | Sell |
7,291
-68
| -0.9% | -$14.3K | 0.01% | 598 |
|
2023
Q1 | $1.49M | Buy |
7,359
+232
| +3% | +$46.8K | 0.01% | 608 |
|
2022
Q4 | $1.55M | Buy |
7,127
+412
| +6% | +$89.8K | 0.01% | 597 |
|
2022
Q3 | $1.32M | Buy |
6,715
+616
| +10% | +$121K | 0.01% | 625 |
|
2022
Q2 | $1.31M | Buy |
6,099
+1,316
| +28% | +$282K | 0.01% | 613 |
|
2022
Q1 | $1.36M | Buy |
4,783
+47
| +1% | +$13.3K | ﹤0.01% | 634 |
|
2021
Q4 | $1.78M | Buy |
4,736
+302
| +7% | +$114K | 0.01% | 575 |
|
2021
Q3 | $1.83M | Buy |
4,434
+155
| +4% | +$64K | 0.01% | 546 |
|
2021
Q2 | $1.58M | Buy |
4,279
+2,447
| +134% | +$905K | 0.01% | 573 |
|
2021
Q1 | $531K | Sell |
1,832
-101
| -5% | -$29.3K | ﹤0.01% | 781 |
|
2020
Q4 | $483K | Hold |
1,933
| – | – | ﹤0.01% | 755 |
|
2020
Q3 | $438K | Buy |
1,933
+48
| +3% | +$10.9K | ﹤0.01% | 729 |
|
2020
Q2 | $329K | Hold |
1,885
| – | – | ﹤0.01% | 773 |
|
2020
Q1 | $238K | Hold |
1,885
| – | – | ﹤0.01% | 806 |
|
2019
Q4 | $288K | Buy |
1,885
+205
| +12% | +$31.3K | ﹤0.01% | 891 |
|
2019
Q3 | $222K | Hold |
1,680
| – | – | ﹤0.01% | 977 |
|
2019
Q2 | $238K | Hold |
1,680
| – | – | ﹤0.01% | 960 |
|
2019
Q1 | $244K | Buy |
+1,680
| New | +$244K | ﹤0.01% | 930 |
|
2018
Q4 | – | Sell |
-1,680
| Closed | -$226K | – | 1066 |
|
2018
Q3 | $226K | Buy |
+1,680
| New | +$226K | ﹤0.01% | 993 |
|